Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging

• Published in: Cancers Vol. 12; no. 3; p. 568
• Main Authors: Jin, Yan, Randall, James W, Elhalawani, Hesham, Feghali, Karine A Al, Elliott, Andrew M, Anderson, Brian M, Lacerda, Lara, Tran, Benjamin L, Mohamed, Abdallah S, Brock, Kristy K, Fuller, Clifton D, Chung, Caroline
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 29.02.2020; MDPI AG
• Subjects: diffusion tensor imaging; glioblastoma; mri; radiation therapy; recurrence; recurrence; diffusion tensor imaging; glioblastoma; MRI; radiation therapy
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers12030568

Glioblastoma is an aggressive brain tumor with a propensity for intracranial recurrence. We hypothesized that tumors can be visualized with diffusion tensor imaging (DTI) before they are detected on anatomical magnetic resonance (MR) images. We retrospectively analyzed serial MR images from 30 patients, including the DTI and T1-weighted images at recurrence, at 2 months and 4 months before recurrence, and at 1 month after radiation therapy. The diffusion maps and T1 images were deformably registered longitudinally. The recurrent tumor was manually segmented on the T1-weighted image and then applied to the diffusion maps at each time point to collect mean FA, diffusivities, and neurite density index (NDI) values, respectively. Group analysis of variance showed significant changes in FA ( = 0.01) and NDI ( = 0.0015) over time. Pairwise t tests also revealed that FA and NDI at 2 months before recurrence were 11.2% and 6.4% lower than those at 1 month after radiation therapy ( < 0.05), respectively. Changes in FA and NDI were observed 2 months before recurrence, suggesting that progressive microstructural changes and neurite density loss may be detectable before tumor detection in anatomical MR images. FA and NDI may serve as non-contrast MR-based biomarkers for detecting subclinical tumors.